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Background: A high proportion of unipolar and bipolar type II patients can present a depressive 
mixed state (DMX). This state is deﬁ  ned by an association of a major depressive episode with at 
least two speciﬁ  c hypomanic symptoms. This state seems underdiagnosed and this could have 
treatment implications. The aims of our study were: (i) to investigate the frequency of DMX in 
type I and II bipolar patients hospitalized for a severe or resistant depressive episode and (ii) to 
assess the therapeutic response in naturalistic conditions.
Methods: Forty-two consecutive bipolar patients referred by psychiatrists for a severe or 
resistant depressive episode were assessed using the French version of the Mini International 
Neuropsychiatric Interview 5.0 (MINI 5.0), which assesses the suicide risk and provides DSM-IV 
diagnosis. The intensity of mood episodes was evaluated using the MADRS and Bech-Rafaelsen 
Mania Scale. One group of patients included patients presenting only depressive symptoms (ie, 
pure major depressive episode (MDE)), and the second group included patients with a major 
depressive episode and at least two speciﬁ  c hypomanic symptoms (DMX).
Results: Twenty-one patients (50%) had a pure MDE and 21 patients (50%) had a DMX. 
The treatment leading to recovery was very different in the two groups. Antidepressants were 
effective (77%) in MDE patients, whereas antipsychotics were effective (81%) in DMX. 38% 
of patients with a MDE also received a mood stabilizer versus 86% in the group of DMX. Five 
MDE patients (24%) and one DMX patient required electroconvulsive therapy. The suicidal 
ideations did not differ between the two groups (p = 0.7).
Conclusions: Some mood episodes in bipolar patients (type I and II) are characterised by depres-
sive and hypomanic symptoms but do not meet criteria for mixed episode as deﬁ  ned by DSM-IV. 
These episodes are often diagnosed as depressive states, but are worsened by antidepressants 
and often considered as resistant depression. They rapidly respond to antimanic treatment. New 
categories of mood disorders should take into account this particular mixed state.
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Introduction
Mixed states are deﬁ  ned by DSM-IV as the co-occurrence of a full manic episode and 
a full depressive episode. Such states are rather uncommon and most authors consider 
that manic episodes associated with depressive symptoms are more frequent (McElroy 
et al 1992, 1995; Bauer et al 1994; Akiskal et al 1998). The DSM-IV (1994) deﬁ  nition 
of mixed states excludes bipolar II disorder. However, major depressive episodes with 
only a few submanic symptoms, called depressive mixed state (DMX), have been 
reported in the literature but not in the DSM-IV (Benazzi 2001a, 2001b, 2003; Benazzi 
and Akiskal 2001; Perugi et al 2001). Benazzi (2001a, 2001b) studied the number of 
hypomanic symptoms during major depressive episodes to assess the prevalence of 
“depressive mixed states” in a cohort of bipolar II and unipolar depressed outpatients. 
He found that 90% of patients had at least one hypomanic symptom, and that 28.5% had 
three or more. However, these symptoms were more frequent in bipolar (BP) II subjects, 
with three or more hypomanic symptoms in 48.7% of subjects. The most prevalent Neuropsychiatric Disease and Treatment 2007:3(6) 900
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symptoms were irritable mood, increased talkativeness, 
distractibility and racing thoughts. These results were 
conﬁ  rmed in a larger collaborative cohort (Benazzi and 
Akiskal 2001). Agitated depressive mixed state with psy-
chotic features has also been found in BP I patients (Perugi 
et al 2001). Most authors concluded that the recognition of 
these affective states is clinically important to protect patients 
from the potentially harmful indiscriminate use of antidepres-
sants and to provide them with the beneﬁ  ts of anticonvulsants, 
short-term neuroleptic treatment or electroconvulsive therapy 
(ECT) (Koukopoulos and Koukopulos 1999).
The aims of this study were: (i) to investigate the fre-
quency of DMX (as deﬁ  ned by an association with a major 
depressive episode and at least two speciﬁ  c hypomanic symp-
toms) in a cohort of type I and II bipolar patients hospitalised 
for a severe or resistant major depressive episode and (ii) to 
assess the therapeutic response in a naturalistic manner.
Methods
We recruited 42 bipolar patients consecutively admitted to a 
speciﬁ  c unit dedicated to mood disorders in Charles Perrens 
Hospital, Bordeaux (France). All these patients were referred 
to the hospital by a psychiatrist for a severe or resistant 
depressive episode. After giving informed consent, patients 
were interviewed using the French version of the Mini 
International Neuropsychiatric Interview (M.I.N.I), provid-
ing DSM-IV Axis I diagnoses (Sheehan et al 1998). We 
divided patients into two groups as a function of the presence 
of hypomanic symptoms. The ﬁ  rst group included patients 
presenting a major depressive state without any hypomanic 
symptom, the pure major depressive episode (EDM). The 
second group included patients with a major depressive state 
associated with at least two speciﬁ  c hypomanic symptoms, 
deﬁ  ning a depressive mixed state (DMX).
We assessed the suicide risk in the two groups. Patients 
were considered to be at risk of committing suicide if they 
answered yes to at least one of the seven questions included 
in the MINI. This risk is characterized by three levels: 
mild = 1; moderate = 2 and high = 3. We also recorded any 
actual suicide attempts. The severity of the mood episode 
was quantiﬁ  ed by the Montgomery and Asberg Depression 
Rating Scale (MADRS) score (Montgomery and Asberg 
1979) and the Bech and Rafaelsen manic scale score (Bech 
et al 1978) in the group of patients with a DMX. Patients were 
considered as recovered when they did not meet criteria for a 
thymic episode and had a score less than 12 on the depression 
scale and less than 6 on the mania scale. We compared the 
treatment leading to recovery in the two groups.
Statistical analyses were performed with the SPSS V.10.0 
software, using the χ2-test and the Student’s t-test for group 
comparisons.
Results
Sample characteristics
This study included 30 (71%) women and 12 men (29%). The 
mean age at interview was 46-years (±17; range). Seventy 
per cent of patients were bipolar type I. Twenty-one patients 
(50%) only met items for major depressive episode, deﬁ  n-
ing the pure MDE group. The same number (21 patients, 
50%) presented a major depressive episode and hypomanic 
symptoms, deﬁ  ning DMX.
Clinical characteristics of the two groups 
(MDE and DMX) (Table1)
Patients with DMX had a mean of 4.95 (±0.86) (range 
3–6) hypomanic symptoms. The 2 most frequent speciﬁ  c 
hypomanic symptoms were: irritability (73%), and racing 
or crowded thoughts (77%).
The scores on the MADRS depression scale were statis-
tically different between the two groups, with a mean score 
of 30 (±7) for the MDE group and 23 (±8) for the DMX 
group (p = 0.008). The mania score in the DMX group was 
13 (±3). Suicidal ideation was present in 17 MDE patients 
(80%) and 15 DMX patients (72%) (p = 0.7). There was 
no difference in the level of suicide risk or the number of 
real suicide attempts between the two groups (respectively 
p = 0.5 and p = 1).
Response to treatment (Table 2)
The treatment leading to recovery was very different between 
the two groups (Table 2). Antidepressants led to recovery 
in 77% of MDE patients. Antidepressants were associated 
with a mood stabilizer in 38% of cases. Thirteen (62%) DMX 
patients were receiving antidepressants upon admission. 
This treatment was discontinued in all cases except two, in 
Table 1 Clinical characteristics of the two groups
 MDE  DMX
Mean of hypomanic symptoms  0  4.95 (±0.86)
MADRS score  30 (±7) 23  (± 8) p  = 0.008
Bech score    13 (±)
Suicidal risk (Yes/no)  17 (80%)  15 (72%)  p = 0.7
Level of risk (mild = 1,  1.86  1.62  p = 0.5
moderate = 2, high = 3)
Suicide attempts  3 (15%)  4 (19%)  p = 1Neuropsychiatric Disease and Treatment 2007:3(6) 901
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which the dose was decreased (these two patients have been 
received antidepressant for many years). In this group, 81% 
of patients recovered when given antipsychotic treatment in 
addition to a mood stabilizer. The antipsychotic was usually 
discontinued before the patient was discharged.
Five patients (24%) in the MDE group and one patient 
in the DMX group needed ECT.
Discussion
This study shows that there are two distinct “depressive 
states” in bipolar patients: pure major depressive episode and 
depressive mixed state as deﬁ  ned by Benazzi (2003). This 
has very important therapeutic implications because major 
depressive episodes classically responded to antidepressant 
medication, whereas depressive mixed states were worsened 
by antidepressants and improved by mood stabilizers associ-
ated with an antipsychotic for a short period. DMX patients 
may be in-patients with type I or II bipolar disease.
The depression scale scores differed between the two 
groups. However, the mean was compatible with the diag-
nosis of depressive episodes in both. Conversely, the mania 
scale score was not very high because most DMX patients 
were only mildly agitated. Indeed, this score was closer to 
those observed in hypomanic episodes rather than in manic 
episodes strengthening that these patients did not respond to 
mixed state as deﬁ  ned by DSM-IV. Although some features 
(particularly the risk of suicide) appeared to be similar in 
the two groups, the response to treatment differed (recovery 
under antidepressant vs recovery under antimanic treatment). 
These two different responses to treatment support the valid-
ity of two distinct depressive states in bipolar patients.
This study highlights the fact that DMX patients are 
worsened by antidepressants, with 62% of these patients 
receiving this type of medication before hospitalization. 
However, hospitalization was required because of an increase 
in suicidal ideation, agitation or a great inner tension. These 
ﬁ  ndings are of relevance to the controversy of antidepressant 
and suicidality in some forms of depression in bipolar patients 
(Dilsaver et al 2005; Mc Elroy et al 2006). DMX state was 
not due to a switch induced by antidepressants because the 
patients did not meet the criteria for a manic, hypomanic or 
mixed state. Moreover, most of these DMX patients were 
considered by their psychiatrist to show resistant depression 
with an indication for ECT. However, only one DMX patient 
required ECT. Akiskal and Mallya (1987), on a case series 
have reported that patients referred for refractory depressive 
states had been over-treated with tricyclic antidepressants and 
had improved with lithium augmentation or with neuroleptics 
used in low dose.
In a recent study, Bottlender and collegues (2004) have 
shown that depressed bipolar I patients with mixed features 
are a high risk for maniform switch during acute treatment. 
This supports the idea for a different treatment response as 
a function of the presence of hypomanic symptoms during 
bipolar depressions.
Our study highlights the problem of the boundaries 
between the different mood states in bipolar patients and 
addresses the issue of the real nature of DMX and its links to 
mixed state, dysphoric mania and hypomanic state (Benazzi 
and Akiskal 2003). This state is characterized by a mixture 
of hypomanic and depressive symptoms, and the treatment 
response is similar to those of mixed states, or manic and 
hypomanic episodes. However, these patients do not ﬁ  t the 
DSM-IV criteria for mixed state, because this state seems 
closer to a mixture of a hypomanic episode and a depressive 
one. Unfortunately, we are unable to classify this state satis-
factorily using the DSM-IV criteria (Benazzi 2001a, 2001b, 
2003; Benazzi and Akiskal 2001).
As the current mood disorder categories are based on the 
tonality of affects, ie, sadness for MDE, and euphoria and 
irritability for manic state, it is difﬁ  cult for a psychiatrist to 
diagnosis a condition other than depression when a patient 
complains of sadness, pain, anxiety or suicidal ideation and 
thus to give him or her a treatment other than an antidepres-
sant. When patients are worsened by this medication, the 
psychiatrist often considers that the patient displays resistant 
depression. However two recent studies have shown efﬁ  cacy 
of atypical antipsychotics in bipolar depression states (Tohen 
et al 2003; Calabrese et al 2005). Thus, further research is 
needed to characterize in which depression bipolar states 
clinicians have to choose either an antidepressant or an 
antipsychotic.
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Table 2 Treatment leading to recovery in the two groups
 MDE  DMX
Antidepressants  16 (76%)  2 (9.5%)  p  0.001
Mood stabilisers  8 (38%)  18 (86%)  p = 0.004
Antipsychotics  3 (14%)  17 (81%)  p  0.001
Benzodiazepines  3 (14%)  3 (14.3%)  p = 1
ECT  5 (24%)  1 (4.8%)  p = 0.18Neuropsychiatric Disease and Treatment 2007:3(6) 902
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